|
HS Code |
646746 |
| Scientific Name | Streptococcus mutans |
| Classification | Gram-positive bacterium |
| Shape | Spherical (coccus) |
| Oxygen Requirement | Facultative anaerobe |
| Primary Habitat | Human oral cavity |
| Role In Disease | Major contributor to dental caries (tooth decay) |
| Motility | Non-motile |
| Spore Formation | Non-spore forming |
| Key Metabolism | Ferments sugars to lactic acid |
| Cell Arrangement | Chains or pairs |
| Cell Wall Composition | Thick peptidoglycan layer |
| Notable Feature | Produces extracellular polysaccharides (biofilm formation) |
| Optimum Temperature | About 37°C |
| Catalase Test | Negative |
| Genus | Streptococcus |
As an accredited Streptococcus Mutans factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Sterile 10 mL glass vial containing lyophilized Streptococcus mutans bacteria, sealed with a rubber stopper and labeled with batch details. |
| Shipping | **Shipping Description for Streptococcus mutans:** Streptococcus mutans is shipped as a viable culture in leak-proof, labeled containers following biosafety regulations. Typically transported at 2-8°C with appropriate cushioning and absorbent material, it is classified as a Biological Substance, Category B (UN 3373). Documentation includes safety data sheets and handling instructions to ensure safe, compliant delivery. |
| Storage | Streptococcus mutans cultures should be stored in tightly sealed containers at -80°C for long-term preservation, typically in a glycerol stock or cryoprotectant solution to maintain viability. For short-term storage, plates or slants can be kept at 4°C. All storage conditions must prevent contamination and dehydration, and containers should be clearly labeled with strain information and storage date for traceability. |
|
Purity 99%: Streptococcus Mutans with purity 99% is used in dental plaque biofilm formation studies, where high purity ensures reliable investigation of cariogenic activity. Cell Viability ≥ 95%: Streptococcus Mutans with cell viability ≥ 95% is used in antimicrobial susceptibility testing, where high viability enables accurate assessment of bactericidal effects. CFU Concentration 1x10⁸/mL: Streptococcus Mutans at CFU concentration 1x10⁸/mL is used in in vitro enamel demineralization models, where consistent bacterial load provides reproducible experimental outcomes. Storage Stability at -80°C: Streptococcus Mutans with storage stability at -80°C is used for long-term microbial culture banking, where stable preservation maintains genetic and physiological characteristics. Optical Density (OD600) 1.0: Streptococcus Mutans at optical density OD600 1.0 is used in biofilm inhibition assays, where standardization of bacterial suspension ensures reliable comparative results. Genotype Confirmed UA159: Streptococcus Mutans genotype confirmed UA159 is used in genetic manipulation research, where strain authenticity supports valid interpretation of mutational effects. Doubling Time < 60 min: Streptococcus Mutans with doubling time less than 60 minutes is used in rapid growth studies, where fast proliferation reduces experimental cycle times. Antibiotic Resistance Profile Characterized: Streptococcus Mutans with characterized antibiotic resistance profile is used in resistance mechanism analysis, where defined traits facilitate targeted drug development. pH Tolerance Range 4.0–7.5: Streptococcus Mutans with pH tolerance range 4.0–7.5 is used in acidic adaptation experiments, where broad tolerance allows simulation of oral cavity conditions. Capsular Polysaccharide Production Quantified: Streptococcus Mutans with quantified capsular polysaccharide production is used in vaccine candidate evaluation, where defined antigenic properties enhance immunogenicity studies. |
Competitive Streptococcus Mutans prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
For decades, Streptococcus mutans has played a central role in dental research, oral microbiology, and infection model development. We deliver pure, well-characterized strains cultivated directly in our GMP-compliant fermentation units. Unlike inconsistent isolates in the open market, our team works under observed, reproducible conditions with traceable provenance and careful process monitoring. Every batch emerges from seed cultures confirmed genetically by PCR and phenotypically verified using traditional plating, ensuring scientists receive strains that match published reference types.
Our main production focus sticks to the widely cited UA159 strain, a type well-documented in dental literature and the Human Oral Microbiome Database. We preserve these cells in glycerol stocks, maintaining genomic integrity for regular scaling. Lyophilized vials contain between 107 and 109 CFU, giving reliable colony counts for reproducibility in serial culture work. No unexpected mutations, no off-character isolates. Each lot receives a unique batch identifier and comes with a living record—our quality control sheet details plating count, Gram staining, and biochemical confirmations such as acidogenesis profile and sensitivity to bacitracin.
Standardizing specifications means less wasted time rerunning controls. Our Streptococcus mutans shows robust growth on mitis salivarius agar and survives repeated freeze-thaw cycles suitable for routine laboratory use. Dedicated researchers appreciate the value of working with a model strain where acidogenicity, colony morphology, and caries-generating phenotypes remain stable from shipment to final experiment. All batches run aerobic and microaerophilic conditions prior to dispatch, and we don't skip full screens for contaminants or off-target bacteria by opportunistic invaders.
Most buyers deploy Streptococcus mutans for dental caries formation models, testing the effectiveness of antimicrobial compounds, studying interspecies biofilm interaction, or for enzymatic work relating to glucan synthesis and acid production. Newer applications have expanded into biofilm eradication technologies, oral vaccine development, and even engineered probiotic therapies using genetically modified variants. We see projects in food safety, environmental sampling, and rapid test kit calibration, as the organism’s metabolic fingerprints provide reliable signals in mixed species communities.
Clinical trial support labs use our Streptococcus mutans to coat hydroxyapatite disks for in vitro caries simulation. Device manufacturers rely on predictable growth kinetics for standardized polishing or disinfection studies. Some clients seek only the wild-type, while others commission custom modification, such as GFP labeling or insertional mutagenesis to knock out specific virulence factors. We receive constant feedback on the need for genetic uniformity and stress tolerance; we regularly validate storage methods and monitor for drift over multiple passages.
In the science of biofilm research and oral health models, predictability saves both time and funding. One sharp distinction between our Streptococcus mutans and what’s available through brokers or teaching collections comes down to the source and control of cultivation. Many academic labs maintain their own small-scale stocks, passed over years or even decades. The risk of mixed culture or genetic drift mounts with each handoff. We eliminate those uncertainties by going back to original clinical isolates, then rigorously re-authenticating every founder stock before seed expansion.
Contamination remains the silent threat in any microbial supply. Low-level carryover from neighboring Streptococcus or Lactococcus can erase months of experimental effort. We operate with closed-system fermenters, not open benchtop shakers, and every raw input for media prep—yeast extract, peptones, salts—receives its own certificate of analysis. Automated plating and verification routines keep human handling minimal. Our staff includes microbiologists who spot deviating morphotypes and metabolic anomalies long before delivery to your bench.
Another crucial difference lies in how our product performs across different experimental setups. Some strains, especially those passed through too many subcultures or under poorly defined atmospheric conditions, lose acid tolerance or fail to produce representative lactic acid concentrations. Feedback from clients teaches us which metrics matter: batch-to-batch growth curves, acidification rates in defined media, and consistency in multi-species co-culture. Poor-performing samples rarely announce themselves straight away—often, only downstream pH readings, failed caries induction, or lackluster glucan staining betray the culprits. We welcome feedback, return cultures for troubleshooting, and swap new vials where problems appear, supporting actual science instead of simply listing off certificate numbers.
A culture’s journey starts before we ever thaw the first cryotube. Our production process puts focus on cleanliness, timing, and documentation. Every worker undergoes regular hands-on training with our on-site microbiologist, ensuring proper aseptic technique. Raw materials, from glassware to fermentation media, feed into a controlled inventory and never come into contact with non-sterile lines. Once seed stock grows to the defined log phase, we harvest under strict temperature controls, immediately transferring to cryopreservation or freeze-drying modules. Lyophilized material spends time in moisture- and light-proof packaging, then ships with temperature indicators so researchers can confirm shipping conditions. Chain of custody matters, and records travel with the batch—not weeks later, but the moment goods arrive at your facility.
Fermentation takes place in stainless steel vessels, maintained for optimal CO2 and O2 balance (not just at “room air,” which too often leads agile strains to diverge or go dormant). Regular spectrophotometer readings check OD600 for real-time population tracking. We avoid unnecessary stress—no overgrowth, no starvation just to wring out another gram of cells. Instead, we recognize that robust, log-phase cells enable better survival through rehydration and offer more reliable downstream results.
Before any vial leaves us, it goes through a three-tiered check: visual colony morphology, Gram staining (smooth purple spheres in short chains, non-hemolytic), and cross-plating on complex, selective, and rich agar types. Our internal documentation details every deviation, however minor, so returns or feedback get a fast, honest answer. More than one researcher has sent us confusing isolates for side-by-side comparison; these deep-dive verifications always highlight why source and manufacturing rigor outpaces re-seller convenience.
The divide between direct manufacturers and resellers appears the moment questions about batch origin, passage history, or specific strain lineages arise. We control every production decision—from which gDNA standard to preserve, to how we space out seed bank renewals. There is no mystery when it comes to answering user concerns: were these cells grown on chemically defined or complex media? Did propagation take place under CO2 enrichment? How many passages since original isolate? Resellers typically lack these details, and working with good faith vendors can become a frustrating exercise in tracing error roots.
End users, from clinical researchers to device makers, deserve certainty. Our documentation doesn’t just state a name and a cell count; it offers a detailed chain of logic, grounded in decades of handling the quirks of Streptococcus mutans. If a client runs into unexpected behavior—say, an anomalous acid tolerance curve or shifting colony shape—we help track down the variables. Was it lab protocol drift or a rare spontaneous mutation? We’ve reviewed logs for everything from subtle genetic rearrangements to missed autoclave cycles. It’s this boots-on-the-ground troubleshooting that ensures both seasoned investigators and first-time graduate students build confidence in their working stock.
Working as a manufacturer arms us with experience in handling the full cycle from isolation to delivery. We’ve fielded calls from researchers struggling with batch inconsistency from indirect sources. After years refining our process, we see how the finer points of fermentation—timing pH drop, ensuring a tight temperature window, rotating out media lots—result in measurable gains in bacterial robustness. Every time a lab transitions from legacy classroom strains to our rigorously prepared cultures, project timelines tighten, and results start replicating more consistently.
Researchers often comment on how much differentiation emerges across suppliers. Some organisms might survive rough handling; others, such as Streptococcus mutans, quickly degenerate outside careful control. Our length of expertise in handling large-scale production doesn’t just prevent drift—it produces a trackable, living archive of each variant generated. Any deviation, even at the level of a single colony, prompts a root-cause investigation, not a cursory pass. Detailed notes follow each transfer and passage; we maintain a long memory for quirks and oddities encountered over the years, protecting customers from legacy problems.
Contamination, even at the lowest levels, defeats scientific intent. Introducing an undetected foreign organism—whether it’s a rogue Lactobacillus, Enterococcus, or even clonal drift within the S. mutans species—invalidates controls and blurs research conclusions. Routine checks only catch so much. It takes a practiced eye and detailed plating to root out off-types. Our quality assurance never assumes “clean enough” means true purity; we reject any lot showing ambiguous morphotypes or sub-optimal fermentation response. Vigilant cross-checking, including PCR and 16S sequencing, back up what classic colony picking and Gram stains reveal.
Stability matters just as much. Subculturing over many generations saps key traits—frequency of glucan-binding, rate of lactic acid output, resistance to various environmental pressures. Many teaching collections unwittingly pass on attenuated, sleepy strains ill-suited for modern laboratory inquiry. Our team parametrizes freeze-drying and glycerolization steps, recording metrics on survival, viability post-thaw, and prolonged storage at -80°C. Protocols update over time, but the end target remains the same: let scientists order today’s vial with the same expectation as next year’s, or the year after that.
Transparency is more than a slogan. With us, every batch number connects to a historical run sheet, linking fermentation date, media batch, technician in charge, and QC summary. If questions ever arise, records sit within arm’s reach for rapid review. Feedback from long-term customers led us to refine our reports—not just stating “meets specification,” but showing the underlying data. It isn’t enough to offer a datasheet; robust manufacturing thrives under honest, granular disclosure. That’s how real trust grows between supplier and researcher community.
Working directly with manufacturing operations, we’ve tracked the ongoing challenges in Streptococcus mutans supply. Global regulations, changing media inputs, transportation restrictions, and shifting academic protocols all influence final performance in the lab. We keep separate inventories for domestic and export-grade lots, recognizing that supply chains introduce risk. Temperature fluctuations in transit, customs delays, or excessive light exposure can all affect cell viability. Our workflow adapts to practical logistics: each shipment uses temperature controls and humidity regulation to maximize stability.
With so many new research demands—and the growth of genetic engineering platforms—our operation anticipates evolving needs. Increasing numbers of labs request sequenced documentation accompanying cultures. We now offer certified whole-genome sequencing as part of premium lots, so traceability matches even the strictest grant funding body or regulatory body requirements. No more guesswork when publishing, running drug screens, or validating clinical devices. If a lab needs modification—antibiotic resistance, gene insertions, or plasmid tagging—we handle all steps internally, saving customers from the roulette of third-party modification providers.
The heart of any scientific manufacturer lies not just in selling products but in supporting those at the edges of discovery. We hear from researchers who spent months troubleshooting unexplained culture failures, only to find basic mistakes in supply sourcing. Keeping close to the workbench, instead of hiding behind resellers or brand names, gives us insight into what matters most. It’s not enough to claim purity or batch repeatability; active engagement with user experience sharpens every stage of our process.
We view every batch of Streptococcus mutans as part of a continuous feedback loop. Customers send back reports, strains for comparison, and notes about odd results. Whenever problems surface—unexpected morphologies, drop in acid output, biofilm formation issues—we get involved. Full replacements, side-by-side growth challenge tests, and frontline troubleshooting inform how we tweak media formulation or re-examine storage practices. Experience running large fermentations, troubleshooting variability, and responding to real-world setbacks turns theory into robust process.
As research grows more precise, expectations from microbial suppliers rise to meet new standards. Twenty years ago, loose-passage strains met most needs; today, genetic integrity, batch documentation, and environmental controls demand much higher rigor. Our growth as a Streptococcus mutans producer follows this curve: continual review of strain libraries, investments in new sequencing platforms, and rapid integration of customer feedback. Innovation doesn’t always mean genetic modification; sometimes the breakthrough is a protocol shift or adopting a better cryopreservation agent.
Provision of true-to-type, contamination-free cultures becomes foundational for publication, regulatory acceptance, patent filings, or even basic laboratory training. We know the frustration of making detailed plans only to discover underlying cultures behave unpredictably. Our direct approach, hands-on production, and visible chain of custody keep projects on stable ground. A research project running on pure, reliable S. mutans offers far more than the sum of its microbial parts—it drives knowledge, speeds up development timelines, and sets new benchmarks for what labs can trust from cultured strains.
We recognize that the uses of Streptococcus mutans stretch beyond classic caries and dental decay research. Newer fields target this organism’s properties for biosensors, synthetic biology chassis development, vaccine antigen testing, and even environmental biofilm management. As industry trends move, our production adapts—experimenting with new preservation technologies, cross-testing polymicrobial co-culture models, and enabling rapid, scale-up lots for device development or clinical simulation.
Sharing manufacturing insights aids not only our clients but the broader scientific community. The methods, checks, and documentation developed by specialist producers raise the floor for everyone. As new requests arrive, whether for rare wild-type variants, genetically engineered derivatives, or application-tailored consortia, our front-line experience ensures future solutions grow from a solid, validated core.
Behind every pure vial of Streptococcus mutans sits a network of process decisions, observations, failures, and successes. Years spent perfecting culture conditions, validating methods, and responding to unexpected issues teach lessons that checklists never capture. As a manufacturer, we operate with the confidence that comes from daily hands-on work. Every improvement in our offering—tighter quality controls, more transparent batch data, better feedback support—emerges from our own problem-solving, not marketing claims.
Whether building a foundational supply for a new academic program, supporting clinical device validation, or troubleshooting rare production challenges, we stand with the scientific community. Each delivered lot brings more than a microbial name; it reflects a commitment to accuracy, predictability, and above all, support drawn from decades of real manufacturing experience.